218617-35-7

Upstream product

• 218617-10-8 p-nitrophenyl O-[6-O-acetyl-2,3,4-tri-O-benzyl-α-D-galactopyranosyl-(1->4)-2,6-di-O-acetyl-3-O-pivaloyl-β-D-galactopyranosyl)]-(1->4)-2,3,6-tri-O-acetyl-β-D-glucopyranoside 
• 251365-48-7 p-nitrophenyl 2,3,6,2',6'-penta-O-acetyl-3'-O-pivaloyl-β-lactoside 
• 148705-01-5 4-nitrophenyl O-(2,6-di-O-acetyl-3,4-O-isopropylidene-β-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-acetyl-β-D-glucopyranoside 
• 148705-02-6 p-nitrophenyl 2,3,6,2',6'-penta-O-acetyl-β-lactoside 
• 814-68-6 acryloyl chloride 
• 251365-49-8 p-aminophenyl O-[α-D-galactopyranosyl-(1->4)-β-D-galactopyranosyl]-(1->4)-β-D-glucopyranoside 

Relevant academic research and scientific papers

Synthesis of an artificial glycoconjugate polymer carrying P(k)-antigenic trisaccharide and its potent neutralization activity against Shiga-like toxin

Fluorescence-labeled glycoconjugate polymers carrying carbohydrate segments of a globotriaosyl ceramide (Gb3) were synthesized and subjected to biological assays using Escherichia coli O-157 strains and Shiga-like toxins (Stx-I and Stx-II). For

Synthesis of artifical glycoconjugate polymers carrying biologically active trisaccharides with α-D-galactopyranosyl (1→3)and (1→4)-linkage

Starting from p-nitrophenyl-β3-lactoside, two types of neoglycoconjugate carrying either a trisaccharide segment of globotriaosyl ceramide (Gb3) or its regioisomerie Galα1,3Gα1β1,4Glc were synthesized via a common intermediate. The former polymer carrying